China Resources Pharma completes RMB400m bond issuance

China Resources Pharmaceutical Group Limited today announced the completion of the second tranche of its 2025 Corporate Bonds in the PRC. The issuance, undertaken by its non-wholly-owned subsidiary CR Pharmaceutical Commercial, raised an aggregate principal amount of RMB400 million. These bonds have a term of three years and carry a coupon rate of 1.93% per annum. The company intends to use the net proceeds from the bond issuance to repay existing interest-bearing debt. Shareholders and potential investors are advised to exercise caution when dealing in the company's securities.